Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Salk

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Science (New York, N.Y.)|June 26, 1981
Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell linesG Yogeeswaran, P L Salk
Research in Immunology|October 1, 1994
Cell-mediated immunologic memory in prevention and treatment of HIV diseaseP L Salk, J Salk
Annals of the New York Academy of Sciences|January 1, 1981
Role of platelets in tumor cell metastasesS Karpatkin, E Pearlstein, P L Salk, et al.
Progress in Clinical and Biological Research|January 1, 1982
Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylationS Karpatkin, E Pearlstein, P L Salk, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell lineE Pearlstein, P L Salk, G Yogeeswaran, et al.
Immunology Today|May 1, 1993
Can AIDS be prevented by T-cell vaccination?H Atlan, M J Gersten, P L Salk, et al.
Research in Immunology|March 1, 1994
Mechanisms of autoimmunity and AIDS: prospects for therapeutic interventionH Atlan, M J Gersten, P L Salk, et al.
Developments in Biological Standardization|January 1, 1981
Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologicsJ C Petricciani, P L Salk, J Salk, et al.
Science (New York, N.Y.)|November 12, 1993
ResponseJ Salk, P A Bretscher, P L Salk, et al.
Science (New York, N.Y.)|May 28, 1993
A strategy for prophylactic vaccination against HIVJ Salk, P A Bretscher, P L Salk, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Science (New York, N.Y.)|June 26, 1981
Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell linesG Yogeeswaran, P L Salk
Research in Immunology|October 1, 1994
Cell-mediated immunologic memory in prevention and treatment of HIV diseaseP L Salk, J Salk
Annals of the New York Academy of Sciences|January 1, 1981
Role of platelets in tumor cell metastasesS Karpatkin, E Pearlstein, P L Salk, et al.
Progress in Clinical and Biological Research|January 1, 1982
Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylationS Karpatkin, E Pearlstein, P L Salk, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell lineE Pearlstein, P L Salk, G Yogeeswaran, et al.
Immunology Today|May 1, 1993
Can AIDS be prevented by T-cell vaccination?H Atlan, M J Gersten, P L Salk, et al.
Research in Immunology|March 1, 1994
Mechanisms of autoimmunity and AIDS: prospects for therapeutic interventionH Atlan, M J Gersten, P L Salk, et al.
Developments in Biological Standardization|January 1, 1981
Theoretical considerations and practical concerns regarding the use of continuous cell lines in the production of biologicsJ C Petricciani, P L Salk, J Salk, et al.
Science (New York, N.Y.)|November 12, 1993
ResponseJ Salk, P A Bretscher, P L Salk, et al.
Science (New York, N.Y.)|May 28, 1993
A strategy for prophylactic vaccination against HIVJ Salk, P A Bretscher, P L Salk, et al.
Pageof 2